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Demythologizing the Stem Cell Juggernaut
Daniel Callahan*
The national debate on embryonic stem cells and research cloning has
brought out the best and the worst in American culture. The best is on display in
many ways. It is a debate that has been marked by an outpouring of sympathy for
those suffering from disease or disability or threatened with death. It has drawn
on the deep historical reservoir in America of a devotion to research and
technological innovation to relieve the human condition. Despite these intensely
partisan times, support for the research has easily crossed party lines, among
legislators and the public. And it has given hope to perhaps thousands of people
suffering from tenacious afflictions and disabilities. Those elements of the debate
are impressive and commendable.
Far less commendable were many of the ways in which the campaign in
favor of the research was waged to gain money to carry it out. The main focus of
this paper is on the early years of the stem cell debate when that effort was most
intense. There were, for openers, inflated claims about the value of the research,
often in the face of cautions from the researchers themselves. There was also an
egregious promotion of what I believe to be an utterly wrong view about a so-
called moral obligation to pursue the research. And there was a full display of
that most ancient of logical fallacies, the ad hominem argument. Many research
proponents did not hesitate to label those on the other side as a noxious coalition
of right-wing religious fanatics, the fearful, the superstitious, the ignorant, and
those invincibly indifferent to human suffering. Some of that kind of rhetoric has
been thrown in my direction. The right, sometimes not to be outdone in throwing
mud, labeled proponents as enemies of human dignity, who were well down a
slippery slope to manufacturing and instrumentalizing human embryos and thus
life itself, the crudest kind of utilitarianism.
There may have been bits of truth in each of these stereotypes, but they did
not serve well to advance the discussion. There were some larger issues at stake
in this conflict, most notably the excessive hype and hyperbole deployed by
research supporters, the use of bad arguments, some ethical window-dressing to
move the cause along, and a failure to take account of some little-noted but
highly relevant facts.
* Ph.D., Senior Researcher and President Emeritus, the Hastings Center. Author of TAMING THE
BELOVED BEAST: How MEDICAL TECHNOLOGY COSTS ARE DESTROYING OUR HEALTH CARE SYSTEM
(2009).
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I confess at the outset that I oppose embryonic stem cell research for either
research or human cloning purposes. It is by now evident that I was on the losing
team and, as someone who thinks of himself as a liberal, I found myself in the
company of many whose values I do not share. I also happen to be pro-choice on
abortion, which probably puts me in some odd, idiosyncratic class, maybe a class
of one.' I will try to reconcile this combination later in the paper.
I most want to demythologize the stem cell juggernaut. The late Protestant
theologian Rudolf Bultmann used the term "demythologize" as a way of
describing his effort to downplay or altogether deny some key beliefs of
Christianity, but without altogether rejecting Christianity. Analogously, I want to
deflate the case made for research cloning but not for, say, adult stem cell
research (even if it is less "promising"). I use the term "juggernaut" to convey
my perception that the force of the research drive, and the public relations work
that was invested in it, were remarkable. If it did not persuade President George
W. Bush to change his mind, it has otherwise swept away most other opposition.
President Barack Obama has already lifted some of the restrictions on the limited
use of embryos now in place in government-supported research, although further
Congressional action is needed before federal funding may be used in the
creation of new cell lines.2 The fact that many states, some of them facing large
budget problems, decided to support the research is just one piece of testimony
about the intensity of the enthusiasm. These states include California,
Connecticut, Illinois, and Wisconsin.3
I. Is THERE A MORAL OBLIGATION To DO EMBRYONIC STEM CELL RESEARCH?
I begin with the leading candidate for demythologization-the claim that
there is some kind of powerful and inescapable moral obligation to carry out the
research.
A. Considerations that Weigh Against a Moral Obligation
Well before the stem cell era, the Nobel Laureate Joshua Lederberg once
said to me that "the blood of those who will die if biomedical research is not
pursued will be upon hands of those who do not support it." Much more recently
the distinguished stem cell researcher, Irving Weissman, used almost identical
1. See DANIEL CALLAHAN, ABORTION: LAW, CHOICE AND MORALITY (1970).
2. See Exec. Order No. 13,505, 74 Fed. Reg. 10,667 (Mar. 9, 2009); Sheryl Gay Stolberg,
New Stem Cell Policy To Leave Thorniest Issue to Congress, N.Y. TIMES, Mar. 9, 2009, at Al;
David Stout & Gardiner Harris, Obama Reversing Stem Cell Limits Imposed by Bush, N.Y. TIMES,
Mar. 7, 2009, at AI, available at http://www.nytimes.com/2009/03/07/us/politics/07stem.html.
3. For a listing of state funding, see James W. Fossett, Beyond the Low-Hanging Fruit: Stem
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language on behalf of stem cell research. According to this line of thought,
regenerative medicine has the promise and potential of saving millions of lives,
afflicted by conditions from heart disease to Alzheimer's, from diabetes to
Parkinson's disease. There is said to be a "negative responsibility" for the lives of
those that could be lost in the absence of the research.
What a rhetorical club to use-but this claim seems specious and
bombastic.4 I advance three considerations to support my view. The first is that
there is a common impression that stem cell research holds out the only hope of
curing various prominent diseases-heart disease, diabetes, Alzheimer's and
Parkinson's disease, and spinal cord injury. Not so. The National Institutes of
Health has invested tens of billions of dollars to cure or ameliorate exactly those
same diseases over the years; and it now invests at least $2.8 billion on them each
year.5 The private for-profit sector has invested at least that much as well, and of
course each of those diseases has an advocacy group that raises additional
research money. Unless we think that the private and public research sectors are
simply squandering their money, which no one has said, and unless we believe
that none of that ongoing research is "promising" (the most oft-repeated term
with stem cell research), then it is simply wrong to assert that the omission of
research cloning would amount to an egregious indifference to human suffering.
Many scientists and others say that embryonic stem cell research is the most
promising approach. But no one (so far as I know) has even dared to offer
statistical probabilities of eventual success, and many are willing to concede that
there may never be a dramatically effective clinical application (though they
usually add that there will be great gains in basic knowledge). 6 In sum, if there is
a moral obligation to do medical research on various deadly diseases, that
obligation is already being discharged. To say that the omission of one line of
research among many others, embryonic stem cell research, constitutes a moral
failure of the first magnitude-"blood on our hands"-is insupportable. But it
certainly plays well.
The second consideration bears on what economists call "opportunity costs":
that is, what else might usefully be done with the money going into stem cell
research? At the same time that the $3 billion California referendum was being
debated, for instance, the newspapers in that state were reporting that 2.2 million
(mainly immigrant) adults were functionally illiterate, almost certainly dooming
4. See DANIEL CALLAHAN, WHAT PRICE BETTER HEALTH?: HAZARDS OF THE RESEARCH
IMPERATIVE (2003).
5. National Institutes of Health, Research Portfolio Online Reporting Tool (RePORT),
Estimates of Funding for Various Research, Condition and Disease Categories (RCDC),
http://report.nih.gov/rcdc/categories (last visited Apr. 30, 2009).
6. Nicholas Wade, Some Scientists See Shift in Stein Cell Hopes, N.Y. TIMES, Aug. 14, 2006,
at A18.
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them to poverty, low level jobs, and little upward mobility.7 The spending of $3
billion on educating them would produce certain and not just promising social
benefits, definite and not just speculative community gains-unlike the
speculative clinical gains from stem cell research. But no celebrities, leading
scientists, biotechnology entrepreneurs, prominent businessmen, or politicians
proposed any referendum on that problem. Nor have many of the states initiating
stem cell research, sometimes into the hundreds of millions of dollars, been
hesitant about simultaneously cutting back on Medicaid benefits, as if the future
benefits for future sick people are more important than present benefits for
present people.
The third consideration bears on medical progress and medical need.
Proponents of the research treat illness and disease as the greatest of threats to
human welfare. I would say they are serious harms but by no means the worst
facing our society. Even more threatening are the failures to provide insurance
for those who do not have it, various forms of inequitable distribution of
available resources of many kinds, global warming, racial and immigrant
prejudices, poor support of working mothers, and many of the harms that were
done to our society by the Bush administration's threats to civil liberties and
sensible social priorities.
The developed countries of the world, including the United States, have an
average life expectancy (accounting for male and female differences) of about
seventy-seven years. This level of life expectancy is perfectly sufficient to sustain
generally healthy, economically successful societies. The fact that heart disease
(a stem cell target) is our nation's leading killer in no sense entails that it should
be considered a major societal problem-unless anything and everything people
die from should be considered a national disaster.
In spite of these indicators of disordered priorities, recent conventional
research and improved clinical care are, for instance, steadily reducing heart
disease mortality. The greatest threat of diabetes does not now come about only
from the lack of a cure, but by increasing obesity, a far harder problem to deal
with than inadequate treatments. It is also obvious that most of the stem cell
target diseases are, save for diabetes and spinal cord injuries, diseases of aging
societies, with heart disease, cancer, and increasingly Alzheimer's at the top of
the list. Unless we think it an inherent evil that people die in old age, and that
nothing less than all-out warfare is required to stamp out diseases that primarily
afflict them, then it is reasonable to give a lower research priority to them.
As far as I can make out, the most evil events of the twentieth century came
from man's inhumanity to man-world wars, genocide, racial and ethnic
7. Felix Montes & Roy L. Johnson, The New State of Illiteracy in San Antonio and the
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violence-not from death by disease, save in poor countries, which are often
bereft of research on those tropical and other diseases (such as malaria) that kill
them. I believe there is an obligation to carry out research on those tropical
diseases as well as HIV/AIDS, which destroys young lives and civic
infrastructures in a way far worse than any disease that might be cured or
ameliorated by regenerative medicine.
None of the considerations I have offered tell against stem cell research as
such, simply against the use of embryos as research material. Adult stem cell
research is fine, and if a way can be found to gain embryonic stem cells without
destroying embryos that is fine as well. Although I do not believe there is any
moral duty to advance the research, to do so could still be considered a human
good, well worth a public and private investment. But if it is characterized as a
good, not an overriding obligation, then it must pass the test of competition and
comparison with other goods that need to be pursued for the sake of a better
society. What I reject is the high pedestal on which it has been set. For a yet-
unproven research possibility, stem cell research does not deserve that honor-
though it surely helps to raise money and generate publicity.
B. The Campaign in Support of Stem Cell Research: Origins of a "Moral Duty"
How did embryonic stem cell research get put on such a high pedestal?
Historians may someday aptly characterize the drive on behalf of stem cell
research as "the perfect PR campaign," one of the best ever waged for medical
research. This campaign began in 1998 with a rash of media stories about James
Thomson's derivation of the first embryonic stem cell lines from frozen human
embryos. 8 Those stem cells, the public was told in often breathless ways, hold
the promise of a whole new medical field, that of regenerative medicine,
restoring damaged or destroyed cells in many organs of the body.
But it soon became evident that there would be opposition to the research-
and particularly against federal support of it-mainly from conservative quarters.
At that point the advocates ratcheted up the campaign. Its organizers, led by well-
funded research advocacy organizations and various scientific societies, turned to
the tried and true methods pioneered in the 1950s by two wealthy philanthropists,
Mary Lasker and Florence Mahoney, at that time on behalf of larger
appropriations for the National Institutes of Health. Their key tactics were to put
together a coalition of prominent scientists, politicians, business people, and
celebrities; amass a war chest to pay for publicity; and skillfully use the media.9
It was a tactic that worked well in the 1950s, and it worked no less well as the
8. James A. Thomson et al., Embryonic Stem Cell Lines Derived from Human Blastocysts,
282 SCIENCE 1145 (1998).
9. Elizabeth Brenner Drew, The Health Syndicate: Washington's Noble Conspirators,
ATLANTIC MONTHLY, Dec. 1967, at 75.
5
Callahan: Demythologizing the Stem Cell Juggernaut
Published by Yale Law School Legal Scholarship Repository, 2009
YALE JOURNAL OF HEALTH POLICY, LAW, AND ETHICS
1990s drew to a close and the new millennium arrived. It also had an added
touch, which did not hurt. Bush's rejection turned out to be, among Bush critics,
an added benefit: if he did not like it, there must have been something going for
it.
The Alliance for Aging Research set the tone with its much-cited claim that
up to 150 million lives could (and would, and should) be saved if the research
was allowed to go forward.'0 Thomas Okarma, CEO of the leading
biotechnology firm, Geron, said that "not to develop the technology would do
great harm to over 100 million patients in the U.S. alone."' A powerful
endorsement of the research by dozens of Nobel laureates from all fields of
science was publicized,' 2 as was a comparable statement of 100 college
presidents' 3 (most of whom, it is fair to assume, are hardly expert on the subject).
Highly supportive public opinion surveys were released, as were enthusiastic
declarations by prominent federal senators and representatives. Christopher
Reeve, Michael J. Fox, and the journalists Michael Krondack and Michael
Kinsley, each the victim of one of the target diseases, played the celebrity role.
The National Academy of Sciences and the Institute of Medicine provided
glowing endorsements. The media had no trouble finding stories about desperate
parents hoping for a cure to their child's diabetes, or spouses taking care of
Alzheimer's patients, or paraplegics trapped in wheelchairs. The real estate
tycoon behind the push for the California bond initiative, Robert N. Klein, spoke
perfectly the inflated language of the national campaign, calling the discovery of
the potential of stem cells "one of the great watershed discoveries in history."' 4
It soon became hard to find many in my field, bioethics, who spoke out
against the research. As a well-known journalist once asked me, "Why are
bioethicists in such lock-step on this issue?" I could think of no answer that
would not bring further embarrassment to a field that likes to think of itself as
open, evenhanded, and non-partisan. Cynicism greeted the appointment of Leon
R. Kass, a longstanding opponent of both reproductive and research cloning, to
chair President Bush's Council on Bioethics. That appointment was railed against
in the press and in bioethics chat rooms, treated as nothing more than a far-right
10. See generally Alliance for Aging Research, Embryonic Stem Cell Research To Save the
Lives of Millions, Spring 2001, http://www.agingresearch.org/content/article/detail/917 (outlining
hopes for future stem cell technologies).
1I. See T. Hviid Nielsen, 10 Years of Stem Cells: What Happened to the Stem Cells?, 34 J.
MED. ETHICS 852, 853 (2008).
12. See Rick Weiss, Nobel Laureates Back Stein Cell Research, WASH. POST, Feb. 22, 2001, at
A2.
13. Tinker Ready ... and ES Cell Strategy, 7 NATURE MED. 518, 518 (2001) (describing the
open letter from college presidents to Health and Human Services Secretary Tommy Thompson).
14. John M. Broder & Andrew Pollack, Californians To Vote on Spending $3 Billion for Stem
Cell Research, N.Y. TIMES, Sept. 20, 2004, at A23.
IX:2 (2009)
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move to put an ethical polish on an intolerable, ideology-driven hostility to life-
saving research. The columnist Robert Kuttner spoke out against the religious
dogmatists standing in the way of the research.' 5 No such label is attached to
those religious figures who oppose the war in Iraq.
Notably missing from the campaign was any recollection of some earlier
advocacy efforts, each accompanied by excitement, hostility toward conservative
critics, and unbounded hopes. Well over a decade ago there was a similarly
controversial effort to support the implantation of fetal tissue in the brains of
Parkinson's patients. It failed, and decisively so. Then there was the effort,
beginning around the same time, to test gene therapy as a means of curing
disease. That therapy has had meager results and, along the way, claimed the life
of a research subject, Jesse Gelsinger. 16 But no letdown seemed quite so striking
as that following the completion of the highly touted $3 billion effort to map the
human genome, the Human Genome Project. Bill Clinton celebrated the end of
that effort by saying it would now be possible to "eradicate once-incurable
diseases."' 7 Such talk is muted these days. It turns out that there are many fewer
human genes than projected, and that in any case proteins-the delivery system
for genetic expression-may be more important for medical applications than
genes alone. The mantle of eradicating "once-incurable diseases" has now been
passed to stem cell research.
There is a scientific response to stories of that kind. Each of the cited failures
or disappointments may not, in the long run, turn out to be failures after all. Good
science takes time, with many disappointments along the way. The contention
that adult stem cells, which can be harvested without embryo destruction, may be
as promising as embryonic stem cells regularly draws a brisk response: the
embryonic form looks theoretically more promising but, whatever view turns out
to be right, good science wants to go down all available roads, never knowing in
advance which will eventually work best. No doubt that kind of general argument
about scientific progress is, historically taken, perfectly true. It is also no less true
that it has provided cover for outlandish and improbable scientific promises and
possibilities.
I raise the issue of hype, however, not as an argument against the research.
Its real harm is that it feeds the notion of a "negative responsibility" or a "moral
obligation" to pursue the research. That latter is an argument meant to disarm
critics, to overcome ethical objections and resistance, and to characterize
opponents as immoral or soft on human suffering. George W. Bush, ironically,
must have been reading the same rhetorical playbook by calling the terrorism
15. For an example of this rhetoric, see Robert Kuttner, When We Trust Science to Religion,
SAN DIEGO UNION-TRIB., Dec. 9, 2001, at G3.
16. Sheryl Gay Stolberg, The Biotech Death of Jesse Gelsinger, N.Y. TIMES, Nov. 28, 1999, §
6 (Magazine), at 137.
17. Gail Collins, Public Interests; A Shot in the Dark, N.Y. TIMES, June 30, 2000, at A25.
7
Callahan: Demythologizing the Stem Cell Juggernaut
Published by Yale Law School Legal Scholarship Repository, 2009
YALE JOURNAL OF HEALTH POLICY, LAW, AND ETHICS
problem a threat to our "national security," and the fight against it a "war." And
those who oppose the "war" are, to be sure, labeled as unpatriotic at best and
indifferent to the suffering imposed by terrorists at worst.
What about the present case: excessive hype or reasonable hope? The
common sense answer is that it is too early to know. But there have been many
warning flags along the way, almost always buried at the end of media stories
that headline new mouse breakthroughs, further lives to be saved, hopes for
support from the new administration, and voices of indignation at the foot-
dragging of George W. Bush (for whom, it should be noted, I did not vote). Yet
even the most hopeful of scientists have been saying, since 1998, that turning the
research promise into useful clinical applications, if possible at all, could take
years or even decades to accomplish.
The May 2005 announcement that South Korean researchers had created
new lines of embryonic stem cells that, for the first time, carry the genetic
signature of diseased or injured patients, and which can be derived in fewer than
twenty tries, signaled a great increase in efficiency. 18 It was hailed by other
scientists as a dramatic and spectacular advance. Yet it all turned out to be a
fraud and an acute embarrassment to the research community. But, if anything,
too much was made of it. Fraud has always been present in science. The main
importance of the South Korean case was to demonstrate that a well-hyped
campaign, with glittering prizes at the end, invites abuse: the greater the prize,
the greater the temptation.
Yet at more or less the same time, in June of that year, James Thomson,
while continuing to call for federal support of the research, laid out a number of
cautions in an interview, in addition to the common scientific reservations about
the long time it will take to get any useful clinical results. He said, as the
interviewer summarized his comments, "that supporters of stem cell research are
overestimating the prospects for transplantation cures, that the current stem-cell
lines [and not just those authorized by President Bush, but new ones as well] are
not well-suited for such applications anyway, and that there's no need to resort to
therapeutic [research] cloning now---or perhaps ever." 19
While I am not competent to assess his scientific views, it is noteworthy that
he had a good word to say for President Bush's compromise position: "[I]t did
get the field started, and I think that's a positive way of looking at it."
20
However, he also echoed a frequent criticism of opposition to stem cell research:
"[M]ost of the people who oppose this research, and most of those who support
this research, do it with a profound amount of misinformation .... [Everyone
18. Gretchen Vogel, Korean Team Speeds Up Creation of Cloned Human Cells, 309 SCIENCE
1096 (2005).
19. Alan Boyle, Stem Cell Pioneer Does a Reality Check: James Thomson Reflects on Science
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should have] real facts.",21 Well, what should we know? Thompson's interview
was interlaced with what he acknowledged to be guesses, uncertain predictions,
and varying future scenarios. What facts, if any, would make the prognostication
more reliable? For the future of financial and political support, it is important to
assess the future of the research. We need to know whether it is a good bet or not,
and so far that remains uncertain. There have been, as of 2008, no striking
breakthroughs on the clinical front, and the fact that some prominent researchers
are now saying that the greatest gain may come from the knowledge generated
rather than for the cure of disease may be telling a different story than the one
initially advanced. The first clinical trial using cells derived from embryonic stem
cells was announced in 2009 (though there was controversy about whether this
trial was premature).22
It is a fact that a great deal of money and energy, and the best of American
public relation and advocacy skills, have been invested in the selling of stem cell
research, particularly the embryonic kind. As the California bond drive
demonstrated, a combination of biotechnology entrepreneurs, wealthy real estate
tycoons, grant-seeking scientists, a muscular governor and other leading
politicians, and an eager public have deeper pockets for advocacy than even the
Southern California religious right. In the United States, any cause that proclaims
improved health and the conquest of disease is usually an easy winner in
ideological combat, especially if its cause is pressed with big money and media
savvy, and given medical credibility by credentialed experts.
II. EMBRYOS, EMBRYOS, AND MORE EMBRYOS: THEORIES ON THE PERSISTENT
DISAGREEMENT OVER THE MORAL STATUS OF THE EMBRYO
I now turn to the moral status of the embryo. For about thirty-five years now
I have puzzled and struggled over that status. Some people have sublime and
calm self-confidence in the rightness of their views on this issue, and this trait
seems to be evenly displayed on the right and left. There is also persistent
perplexity on the part of many others-that is, most of us. Wherever one stands,
however, it might readily be agreed that there is no end of the disagreement in
sight. I have puzzled about why it is hard to achieve consensus. As my wife (pro-
life) and I (pro-choice) long ago noted, after decades of argument, we each know
all the relevant science and all the relevant moral and philosophical arguments; it
is hard to find anyone who can say anything new to either of us. Still, we
disagree. I have three theories about this difficulty of overcoming disagreement:
one bears on our interests and self-interests, another on our modes of moral
analysis, and the third on devising public policy and a regulatory framework for
research.
21. Id.
22. Andrew Pollack, Milestone in Research in Stem Cells, N.Y. TIMES, Jan. 23, 2009, at B1.
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A. Interests and Self-Interests
My way of understanding the methodological problems of determining the
moral status of the embryo, which has helped me to see why there is no decisive
general method of solving problems that mix scientific evidence and moral
evaluation, has ineluctably (and sometimes unpleasantly) led me to consider the
role played in the process by our interests and self-interests. There are two ways
of framing the problem I want to point to. One of them has been to ask why it is
that the passions run so high for pro-life and pro-choice advocates in the abortion
wars. Each of them has, in my observation, invested their stand with symbolic
and policy considerations that go beyond abortion and the moral standing of
embryos (or fetuses). Let me call this the "interest" problem: important matters
are at stake, bearing on what each side sees as the kind of world in which they
want to live, and the only kind of world that anyone should want to live in.
For many feminists, abortion has been a decisive index issue, one whose
outcome determines what women's role and social status will be in many areas
other than reproduction. If we lose that battle, they have in effect said, we will
have lost the war for women's rights. For pro-life advocates, the moral status of
embryos and fetuses is no less a decisive index issue, determining how we think
of and treat the weakest and most defenseless among us. If we lose this battle,
they are saying, we will have lost the war for human dignity. At the extremes,
some pro-choice feminists say that the moral status of embryos and fetuses is
solely a matter of a woman's decision: they have value insofar as women confer
value on them-and that is the kind of absolute power women should have. For
their part, some pro-life proponents want abortion, however early the stage, to be
understood as nothing less than murder of the innocent, justifying for some
violence and non-peaceful protest against those who carry out such atrocities.
These attitudes are mainly found at extreme edges of the abortion struggle, but
they are less surprising (if not less disturbing) when it is understood that there are
larger causes and concerns at stake, of which the moral status of the fetus is the
tinderbox, not the whole story.
What I will call the "self-interest" problem raises a number of delicate
puzzles. By this I mean the extent to which people, wittingly or unwittingly,
allow their self-interest to determine their moral judgments. If my reading of the
methodological problem of determining the moral status of the embryo is
plausible-we lack any decisive criteria for making a decision-the self-interest
issue must consequently raise its head. The way is open, and it is a wide avenue,
for the introduction of ideological, political, and self-interested judgments. That
is what patently appears to happen.
At least two senses of self-interest can be distinguished. One of them is what
might be called acceptable or legitimate self-interest: a minority group seeking an
end to discrimination against itself, the disabled lobbying for access to public
IX:2 (2009)
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facilities, or homeowners seeking the end of industrial pollution practices that
threaten their water supply or the health of their children. Each group seeks
something of direct benefit to them, perhaps of no particular benefit to the rest of
the community, and perhaps even imposing some burdens on everyone else-but
it is considered a legitimate claim and a tolerable burden even on those who have
nothing special to gain.
But then there is what I will call an ambiguous sense of self-interest, which
might be those situations where we at least wonder if the self-interest is crass,
that is, where narrowly self-serving desires are at stake. Here we might think of
the industrial polluter who knows that there is hazardous pollution that it could
well afford to stop. But it persuades itself that the pollution is not all that bad,
that nature will eventually take care of it as it biodegrades, and that any serious
efforts on its part would endanger its economic strength and thus put at risk the
many jobs the community needs. I stress in this example that the company
"persuades itself," in order to recognize that most people who display crass self-
interest may admit that some self-interest is at stake but not the grossly self-
serving kind.
What are we to make of embryonic research scientists who, we assume, must
have persuaded themselves that embryos do not have a high enough moral status
for concern, and maybe none at all, and thus see no problem in using them for
their research? Is it a mere coincidence that, seemingly, only a handful of
scientists interested in doing the research appear to have any serious dilemma
about using embryos, a far lower proportion than the population as a whole? This
can be seen as a classic chicken-egg problem: which came first, their desire to do
the research and thus an adaptation of their moral stance toward embryos through
self-persuasion; or was there a preexisting stance toward embryos that made it
morally tolerable to use them for research?
The same kind of questions can be raised about the lay supporters of the
research and particularly those suffering from some disability or life-threatening
disease that the research might alleviate. At the least we might say that, for those
who want the research to go forward, there are some powerful disincentives
against granting embryos so high a status that the research could not proceed. Or,
to put it a different way, if the destruction of embryos is understood to be one of
balancing their value against that of research benefits, it is not exactly
unpredictable that many people will persuade themselves that embryos have a
lesser value than those benefits.
I focus on this line of thought because, if science cannot tell us what the
moral status of an embryo is, and therefore if the moral values at stake must, so
to speak, be imported from the outside, then there is room to seek those moral
principles and modes of reasoning most compatible with our other values. If we
are as scientists eager to carry out the research, and as patients eager to have its
benefits, we will be likely to bring those values to bear on our assessment of
11
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embryos-and to decide against them. But my mode of analysis here cuts two
ways: for those who see in various forms of scientific research a threat to human
dignity (an important value for their way of life) or the beginning of a slippery
slope, they have a powerful incentive to give the embryo a high and inviolable
status.
I do not conclude from my line of analysis that the obvious self-interest of
either the researchers or their opponents is a matter of crass self-interest;
however, I also do not believe that either group is disinterested. The scientific
interests of researchers (their notions of the goods to be pursued) are best served
by minimizing the moral status of embryos, just as the moral interests of
opponents (their notions of the higher goods at stake) are served by maximizing
it. What all of this proves to me is that the ambiguous status of the embryo-
inescapable since it requires a mode of combined scientific/moral analysis for
which we have no good methods-invites and perhaps makes necessary the
introduction of values and perspectives drawn from other ways of understanding
what we take to be the human good; and these values and perspectives open the
way for a self-interested stance. It only gets crass when our own view of what
that good might be is utterly self-serving. I do not hesitate to ascribe this
judgment to the view of some feminists that the value of the embryo depends
entirely on the value a woman chooses to confer upon it, or to politicians who
boorishly court conservative support for their election by pandering to pro-
embryo forces, treating their enemies as killers.
B. Moral Analysis, Uneasiness, and "Respect":
Deriving an "Ought "from an "Is"
There persists a widespread conviction that the answer to the status of the
embryo can be found in science. Hence, there are endless debates about the
embryological evidence, about whether one can speak of a pre-embryo, about
whether human life could someday be derived from a single skin cell, about
whether more scientific evidence might one day solve the problem, and so on.
But to ask about the moral status or standing of an embryo is an ethical question,
and if there was ever an instance when it is not possible logically to derive an
ought from an is (known to philosophers as the naturalistic fallacy), this is it.
Science may eventually be able to empirically explain everything to be
known about embryos, their genesis, and their development. But it is beyond the
capacity of science to tell us how we ought to treat embryos or evaluate their
moral status. That evaluation falls into the category of issues that requires a blend
of empirical analysis and moral judgment, but each mode of reasoning draws
upon different methods and standards of judgment. To further complicate
matters, those different forms of judgment can influence each other: our moral
concerns can lead us to look at one among many aspects of the scientific
evidence, selecting those that seem relevant (itself a non-scientific judgment),
IX:2 (2009)
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while the scientific evidence can lead us to reconsider our moral judgments,
sometimes whether we like it or not.
Could one conclude from my analysis above that there is nothing more to an
evaluation of the moral status of the embryo than our various interests and self-
interests at play and manifesting our different views of the good life? There are
surely some grounds for thinking so, but there are some reasons to hesitate as
well. While there are many research proponents who seem to believe that
embryos have no value whatever, they seem to be in the minority. I characterize
the stance of many if not most proponents as one of uneasiness, displaying some
residual uncertainty about the status of embryos. This uneasiness seems to me to
come out in a number of ways: an acknowledgement that, if implanted and not
destroyed, embryos have the potential to develop into full persons; a reluctance,
other than as a last resort, to create embryos solely for research purposes; an
aversion to commercializing the use of embryos, and finally by the adoption of
the word "respect" as an apparent effort to find a symbolic compromise
characterization of what we owe embryos.
Just what is it that bothers people, even those readily willing to trade off
embryos for valuable research? I cannot say for sure, but I suspect that, however
much some philosophers may deride the importance of potentiality ("acorns are
not oak trees, are they?"), it is hard to entirely put out of our mind and emotions
that we all began as embryos; undeniably they are part of everyone's personal
history. Even if, as is customary, a distinction is made between the beginning of
individual life, on the one hand, and protectable moral standing on the other, that
beginning is hard to ignore.
But I can only speculate about the sources of the uneasiness. I want to take a
look instead at the word "respect," a much-employed way of placating and
domesticating the discomfort. A 1979 report of the Ethics Advisory Board of the
Department of Health, Education, and Welfare stated that the early embryo
merits "profound respect," though not all "the full legal and moral rights
attributed to persons."23 A 1994 NIH Human Embryo Research Panel said that
"the preimplantation human embryo warrants serious moral consideration as a
developing form of human life.",24 The National Bioethics Advisory Commission
said in 1999 that "human embryos deserve respect as a form of human life.,
25
Since the context of that usage of "respect" is that of the destruction of the
embryo, this amounts to what I would call cosmetic ethics. The dictionary
23. Office of the Sec'y, Dep't of Health, Educ., & Welfare, Protection of Human Subjects:
HEW Support of In Vitro Fertilization and Embryo Transfer: Report of the Ethics Advisory Board,
44 Fed. Reg. 35,033, at 35,056 (June 18, 1979).
24. 1 NAT'L INST. OF HEALTH, REPORT OF THE HUMAN EMBRYO RESEARCH PANEL, at x (1994),
available at http://bioethics.gov/reports/past-commissions/human-embryo-vol-1.pdf.
25. 1 NAT'L BIOETHICS ADVISORY COMM'N, ETHICAL ISSUES IN HUMAN STEM CELL RESEARCH,
at ii (1999), available at http://bioethics.georgetown.edu/nbac/stemcell.pdf.
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definitions of "respect" appear to leave little room for its use as a balm to the
conscience, demanding something more of us than a deferential nod in their
direction as they are destroyed strictly for our ends, not their own. Their death is
certain, the research results wholly speculative. Try fitting the notion of respect
as used by the various commissions into the standard dictionary definitions of
respect: "1. To feel or show esteem for; to honor; 2. To show consideration for;
avoid violation of, treat with deference. 26
How can I criticize this symbolic deference paid to embryos and, at the same
time, defend the legalization of abortion? In the most defensible abortions, for a
serious threat to a woman's health or the certain likelihood of a crippling genetic
defect for her embryo or fetus, an abortion can have almost certain beneficial
results, at least from the perspective of a woman who believes that it is necessary.
Hence, the destruction of the embryo (or, much more likely, a fetus) in that case
brings an almost certain benefit to a woman: a life is taken but another life gains,
and in that case a life already fully developed gains, not hypothetical future
patients who may, in any event, be cured by means of research other than the use
of stem cells. I would not want to call the destruction of the embryo or fetus in
that case a respectful act, even for a defective fetus. This is still destruction pure
and simple, but for very different reasons than clinical research. In short, a
different kind of case can be made for abortion, with equally deadly results, than
can be made for embryo research. An acceptance of abortion does not entail an
acceptance of embryo destruction for research purposes.
C. Public Policy: Embryonic Stem Cell Alternatives, Excess Embryos, and
Regulation of Research
I have already tried to make the case that there is no moral obligation to
pursue embryonic stem cell research, particularly in light of the vast amount of
money already being spent to combat the same conditions at which the research
is aimed. Whether the various ideas for deriving stem cells by means other than
embryo destruction will succeed is uncertain at this writing, but it would appear
to be a worthy goal. That very effort has been challenged on the grounds that
there are already thousands of frozen embryos available for research, otherwise
to be discarded. That is a tantalizing argument, hard to resist because of its
commonsensical nature. Even so, on balance I do resist it, but for a cluster of
reasons, not one in particular.
Excess frozen embryos exist as a result of IVF, which in itself seems to me
perfectly acceptable. Must less acceptable are the reasons why there are so many
frozen embryos available. Most of them come from the treatment of infertile
women, but most (though not all) of those women are infertile because of two
well-known causes, late procreation and sexually transmitted infection. I would
26. T4E AMERICAN HERITAGE DICTIONARY OF THE ENGLISH LANGUAGE 1107 (1 st ed. 1969).
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classify excess embryos, then, as a public health problem-yet one that we have
medicalized as an inherent biological problem, to be clinically treated rather than
the subject of efforts to change the underlying cause (particularly creating social
and economic contexts that encourage women to procreate earlier rather than
later, in their twenties rather than thirties).27 Of late, it might be mentioned,
efforts are underway to improve IVF to reduce the number of spare embryos, and
of course there have been many scientific doubts about whether many or most
frozen embryos would be useful anyway.28 I will not take up here the effort to
find ways of gaining stem cells without destroying embryos, but it is an
obviously useful effort.
I am not greatly impressed with the argument that spare embryos will be
destroyed anyway, and that their use in research is better than simply wasting
them. I come to that judgment for a variety of reasons, not one of which is (even
to me) fully persuasive in itself, but which add up to a moral gestalt that tilts me
against that use: 1) spare embryos need not, and should not exist in the first
place-they enhance the chances of an eventual pregnancy, but do not guarantee
it, and the recent efforts to reduce their number reflects, at least in part, some
level of discomfort; 2) research on dying human beings without their informed
consent was once accepted in medical research on the grounds that they were
dying anyway and it would be a waste not to make use of them; 3) the one-time
(now defrocked) champion of euthanasia, Dr. Kevorkian, contended that the
organs of those who were going to suffer capital punishment should routinely be
salvaged without their consent because, after all, they were going to be dead
soon, and thus would have no further use for their organs and that-clincher of
clincher-the salvaged organs could save lives (and Chinese penal authorities
have used an identical argument); and 4) the Nazi doctors, who did all kinds of
horrible things to concentration camp inmates prior to their certain death in the
name of medical research, consoled themselves with the thought of all the
medical benefits that could accrue from enlisting the inmates without consent.
The research was mainly useful for militarily valuable purposes but at least some
seems to have been for saving lives in general. Do we want contemporary
medical research placed in such unsavory company? As I said, there is a response
to each of the points (we're not Nazis, Chinese penal authorities, or Kevorkian-
just good people trying to reduce suffering and death), but their net weight leaves
a bad odor in the room, too much for me, at any rate. I would be more impressed
with Gene Outka's argument based on a "nothing is lost" principle if I believed it
legitimate to have spare embryos, which I do not (it is not medically necessary),
and if I believed that there was some obligation to carry out research with
embryos, which I do not either. I would argue that "nothing is lost"-to turn
27. See REPRO-GEN ETHICS AND THE FUTURE OF GENDER (Frida Simonstein ed., forthcoming
June 2009).
28. Gretchen Vogel, Embryo-Free Techniques Gain Momentum, 309 SCIENCE 240 (2005).
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Outka's argument on its head-by not doing the research at all (as I explained
earlier).
CONCLUSION
I conclude with a few observations on the regulation of stem cell research.
For at least three decades, the strategy of choice for dealing with morally
controversial scientific initiatives which have strong scientific support has been
to establish commissions, which propose some limits and then turn the problem
over to a regulatory approach. The National Academy of Sciences on stem cell
research put together a commission that set forth a number of regulatory ideas
(hoping, it appears, to avoid a similar government move), and the state of
California as well as some academic research centers have set standards for
carrying out the research. 29 But we should not expect commissions and
regulations to stop the research. Their purpose is to reduce anxieties about it and
to curtail evident abuses. It would be a miracle if any ardent research opponents
were appointed members of those commissions or asked to help write the
regulations. The aim of the commissions is, after all, to facilitate the research-to
make sure it goes forward-but in ways that keep hostile legislators and a
worried public at bay. 30 That's the American way, and it well serves those ends,
even if at times we pay an ethical price for it. The most important price is that it
allows us to keep going with the research but salves our conscience in the
process, and it is hardly noticed.
I end my paper with one sentence. The moral status of early embryos is
weak and uncertain, but not nearly as weak as the moral status of research
cloning.
29. See COMM. ON GUIDELINES FOR HUMAN EMBRYONIC STEM CELL RESEARCH, NAT'L
RESEARCH COUNCIL, GUIDELINES FOR HUMAN EMBRYONIC STEM CELL RESEARCH (2005), available
at http://www.nap.edu/openbook.php?isbn=0309096537.
30. JOHN H. EVANS, PLAYING GOD? HUMAN GENETIC ENGINEERING AND THE RATIONALIZATION
OF PUBLIC BIOETHICAL DEBATE (2002).
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